{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:56:20Z","timestamp":1788544580849,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT093223AIA"],"award-info":[{"award-number":["WT093223AIA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT085523MA"],"award-info":[{"award-number":["WT085523MA"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C5255\/A15935"],"award-info":[{"award-number":["C5255\/A15935"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuropharm.2015.07.018","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T01:18:38Z","timestamp":1437182318000},"page":"210-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-967X","authenticated-orcid":false,"given":"Aisling","family":"Spain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre A.","family":"Khrapitchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola R.","family":"Sibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.07.018_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuropharm.2011.01.015","article-title":"Serotonergic regulation of neuronal excitability in the prefrontal cortex","volume":"61","author":"Andrade","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib2","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1523\/JNEUROSCI.5015-08.2009","article-title":"The BOLD response in the rat hippocampus depends rather on local processing of signals than on the input or output activity. A combined functional MRI and electrophysiological study","volume":"29","author":"Angenstein","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroimage.2004.08.011","article-title":"Confounding effects of anesthesia on functional activation in rodent brain: a study of halothane and alpha-chloralose anesthesia","volume":"24","author":"Austin","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib4","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1523\/JNEUROSCI.6063-09.2010","article-title":"Negative blood oxygen level dependence in the rat: a model for investigating the role of suppression in neurovascular coupling","volume":"30","author":"Boorman","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2027","article-title":"A\u00a0role for fMRI in optimizing CNS drug development","volume":"5","author":"Borsook","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01062336","article-title":"Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics","volume":"10","author":"Boxenbaum","year":"1982","journal-title":"J.\u00a0Pharmacokinet. Biopharm."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2007.11.008","article-title":"Inhibition and brain work","volume":"56","author":"Buzs\u00e1ki","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib8","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib10","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1523\/JNEUROSCI.3065-04.2004","article-title":"Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways","volume":"24","author":"Cauli","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0301-0082(96)00033-0","article-title":"Serotonin in the regulation of brain microcirculation","volume":"50","author":"Cohen","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00401509","article-title":"A\u00a0possible correlation between drug-induced hallucinations in man and a behavioural response in mice","volume":"11","author":"Corne","year":"1967","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroimage.2013.02.046","article-title":"Systemic inflammation alters central 5-HT function as determined by pharmacological MRI","volume":"75","author":"Couch","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib14","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1073\/pnas.0407789102","article-title":"Coupling of the cortical hemodynamic response to cortical and thalamic neuronal activity","volume":"102","author":"Devor","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib15","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuroimage.2009.06.021","article-title":"Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups","volume":"47","author":"Fleisher","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.neuroimage.2010.03.060","article-title":"The effect of different anesthetics on neurovascular coupling","volume":"51","author":"Franceschini","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1468-2982.2002.00395.x","article-title":"Effects of sumatriptan on cerebral blood flow under normo- and hypercapnia in rats","volume":"22","author":"Fukuda","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ejn.12024","article-title":"Effects of the \u03b12-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex","volume":"37","author":"Fukuda","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","article-title":"Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG","volume":"20","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pharmthera.2010.06.005","article-title":"The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B\/1D) and CGRP receptors","volume":"128","author":"Gupta","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-014-3855-0","article-title":"A\u00a0systematic review of physiological methods in rodent pharmacological MRI studies","volume":"232","author":"Haensel","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/japplphysiol.00954.2005","article-title":"Perivascular nerves and the regulation of cerebrovascular tone","volume":"100","author":"Hamel","year":"2006","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00004647-200208000-00002","article-title":"Origin of negative blood oxygenation level-dependent fMRI signals","volume":"22","author":"Harel","year":"2002","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0031-6865(97)00014-9","article-title":"Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man","volume":"72","author":"Hasler","year":"1997","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib29","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jcbfm.2012.23","article-title":"Biophysical and physiological origins of blood oxygenation level-dependent fMRI signals","volume":"32","author":"Kim","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroimage.2013.03.002","article-title":"Test-retest reliability of task-related pharmacological MRI with a single-dose oral citalopram challenge","volume":"75","author":"Klomp","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2012.05.031","article-title":"Vasoconstrictor 5-HT receptors in the smooth muscle of the rat middle cerebral artery","volume":"689","author":"Kov\u00e1cs","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib32","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.neuroimage.2012.01.040","article-title":"Neuronal inhibition and excitation, and the dichotomic control of brain hemodynamic and oxygen responses","volume":"62","author":"Lauritzen","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib33","first-page":"1202","article-title":"Applications and limitations of interspecies scaling and in\u00a0vitro extrapolation in pharmacokinetics","volume":"26","author":"Lin","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature06976","article-title":"What we can do and what we cannot do with fMRI","volume":"453","author":"Logothetis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroimage.2006.02.021","article-title":"Investigating neural-hemodynamic coupling and the hemodynamic response function in the awake rat","volume":"32","author":"Martin","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib36","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.neuropharm.2008.08.014","article-title":"Pharmacological MRI in animal models: a useful tool for 5-HT research?","volume":"55","author":"Martin","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2012.10.006","article-title":"Complex spatiotemporal haemodynamic response following sensory stimulation in the awake rat","volume":"66","author":"Martin","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jmri.23914","article-title":"Functional MRI in conscious rats using a chronically implanted surface coil","volume":"38","author":"Martin","year":"2013","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0163-7258(94)90048-5","article-title":"Vascular receptors for 5-hydroxytryptamine: distribution, function and classification","volume":"62","author":"Martin","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1460-9568.2009.06812.x","article-title":"Dose-dependent effect of isoflurane on neurovascular coupling in rat cerebral cortex","volume":"30","author":"Masamoto","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/schbul\/sbt086","article-title":"Altered amygdala connectivity within the social brain in schizophrenia","volume":"40","author":"Mukherjee","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib42","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1177\/0269881110372547","article-title":"Using MRI to measure drug action: caveats and new directions","volume":"25","author":"Murphy","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"5736","key":"10.1016\/j.neuropharm.2015.07.018_bib43","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.1110948","article-title":"Hemodynamic signals correlate tightly with synchronized gamma oscillations","volume":"309","author":"Niessing","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12035-011-8214-0","article-title":"Serotonin and prefrontal cortex function: neurons, networks, and circuits","volume":"44","author":"Puig","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","article-title":"Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers","volume":"37","author":"Quednow","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.07.018_bib47","doi-asserted-by":"crossref","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.dcn.2013.07.003","article-title":"The BOLD signal and neurovascular coupling in autism","volume":"6","author":"Reynell","year":"2013","journal-title":"Dev. Cogn. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.07.018_bib49","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1017\/S1461145714000261","article-title":"The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs","volume":"17","author":"Riga","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib50","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.neubiorev.2013.07.018","article-title":"Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies","volume":"37","author":"Rive","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/nbm.1940070106","article-title":"Functional MRI of CO2 induced increase in cerebral perfusion","volume":"7","author":"Rostrup","year":"1994","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib52","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.neuroimage.2006.11.010","article-title":"In\u00a0vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI","volume":"34","author":"Schwarz","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-0270(03)00192-4","article-title":"A\u00a0template for spatial normalisation of MR images of the rat brain","volume":"129","author":"Schweinhardt","year":"2003","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib54","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1523\/JNEUROSCI.3447-08.2009","article-title":"A\u00a0new scenario for negative functional magnetic resonance imaging signals: endogenous neurotransmission","volume":"29","author":"Shih","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nn1675","article-title":"Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1","volume":"9","author":"Shmuel","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib56","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.neuroimage.2004.12.010","article-title":"Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals","volume":"25","author":"Sicard","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(01)03121-3","article-title":"Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons","volume":"922","author":"Szabo","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib58","first-page":"S145","article-title":"Dynamic recording of ongoing neurovascular activity in awake-behaving mice","volume":"29","author":"Takuwa","year":"2009","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib59","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1523\/JNEUROSCI.3346-12.2013","article-title":"Locus coeruleus stimulation recruits a broad cortical neuronal network and increases cortical perfusion","volume":"33","author":"Toussay","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuroscience.2009.10.006","article-title":"Effects of isoflurane and alpha-chloralose anesthesia on BOLD fMRI responses to ingested L-glutamate in rats","volume":"165","author":"Tsurugizawa","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib61","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.07.018_bib62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib63","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib64","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.neuroimage.2005.08.028","article-title":"A\u00a0fully noninvasive and robust experimental protocol for longitudinal fMRI studies in the rat","volume":"29","author":"Weber","year":"2006","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neuropharm.2015.07.018_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A","article-title":"Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex","volume":"27","author":"Willins","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib66","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuroimage.2009.10.013","article-title":"Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study","volume":"49","author":"Windischberger","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib67","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jmri.20584","article-title":"The role of fMRI in drug discovery","volume":"23","author":"Wise","year":"2006","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neuropharm.2015.07.018_bib68","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/jcbfm.1992.127","article-title":"A\u00a0three-dimensional statistical analysis for CBF activation studies in human brain","volume":"12","author":"Worsley","year":"1992","journal-title":"J.\u00a0Cereb. Blood Flow Metab."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815300241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T16:58:41Z","timestamp":1537462721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815300241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":68,"alternative-id":["S0028390815300241"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}